SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-245272
Filing Date
2020-09-14
Accepted
2020-09-14 17:00:54
Documents
2
Group Members
CHART WESTCOTTIKARIAN HEALTHCARE FUND GP, L.P.IKARIAN HEALTHCARE MASTER FUND, L.P.NEIL SHAHRESTANI

Document Format Files

Seq Description Document Type Size
1 SC 13G d64619dsc13g.htm SC 13G 132507
2 EX-99.1 d64619dex991.htm EX-99.1 10041
  Complete submission text file 0001193125-20-245272.txt   144365
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Subject) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88629 | Film No.: 201173773
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201
Business Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201 214-364-2883
Ikarian Capital, LLC (Filed by) CIK: 0001778253 (see all company filings)

IRS No.: 473466768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G